Eye News and Research

Latest Eye News and Research

Free educational event for patients with Graves' disease and thyroid eye disease

The Massachusetts Eye and Ear and the Graves' Disease & Thyroid Foundation will host a free educational event for patients living with Graves' disease and thyroid eye disease on Saturday, May 10 from 8:30 a.m. to noon at Mass. Eye and Ear's Meltzer Auditorium, 3rd floor, 243 Charles Street, Boston, Mass., 02114.

30 Apr 2014

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia and Alimera Sciences.

28 Apr 2014

Antimicrobial peptide coated contact lenses may reduce risk of contact lens-related infections

Contact lenses coated with an antimicrobial peptide could help to lower the risk of contact lens-related infections, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

25 Apr 2014

Prestige Brands Holdings signs agreement to acquire Insight Pharmaceuticals for $750 million

Prestige Brands Holdings, Inc. today announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter ("OTC") healthcare products, for $750 million in cash.

25 Apr 2014

NovaBay introduces new eye care product to help patients with eyelids irritation

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that it is introducing a new eye care product, i-Lid Cleanser.

23 Apr 2014

Kala Pharmaceuticals completes $22.5 million Series B financing

Kala Pharmaceuticals, Inc., a leading developer of innovative ophthalmic products based on the company's proprietary Mucus Penetrating Particle (MPP) platform technology, today announced it has completed a $22.5 million Series B financing.

23 Apr 2014

Glaucoma drug may help reverse obesity-related vision loss in women

An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension (IIH), according to a study funded by the National Institutes of Health.

23 Apr 2014

Sleep disorder is the best current predictor of brain diseases, say U of T researchers

Researchers at the University of Toronto say a sleep disorder that causes people to act out their dreams is the best current predictor of brain diseases like Parkinson's and Alzheimer's.

22 Apr 2014

NBTY introduces Nature's Origin, a complete line of nutritional supplements

NBTY, Inc., a leading global manufacturer and distributor of high-quality vitamins and nutritional supplements, introduces Nature's Origin, its first complete line of vitamins, minerals and herbal supplements that are free from ingredients made with GMOs, preservatives, gluten and irradiation.

22 Apr 2014

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.

22 Apr 2014

Study evaluates stigma and public perceptions related to lung cancer

It's not uncommon these days to find a colored ribbon representing a disease. A pink ribbon is well known to signify breast cancer. But what color ribbon does one think of with lung cancer?

22 Apr 2014

ResMed launches new nasal and full face masks

ResMed expands its ultra-light, comfortable, and award-winning AirFit™ line of masks today with new nasal and full face options.

From ResMed Corp 22 Apr 2014

Scientists examine Gpr109a receptor to find potential treatment for diabetic retinopathy

Like a daily pill to lower cholesterol can reduce heart attack and stroke risk, an easy-to-use agent that reduces eye inflammation could help save the vision of diabetics, scientists say.

22 Apr 2014

U.Va. researchers named recipients of 2013 Hartwell Individual Biomedical Research Awards

University of Virginia neurologist Dr. Erin Pennock Foff, biologist Sarah Kucenas and biomedical engineer Shayn Peirce-Cotter have been named recipients of 2013 Hartwell Individual Biomedical Research Awards to benefit children of the United States. Each scientist will receive $100,000 in direct annual research support from The Hartwell Foundation for three years.

19 Apr 2014

Three Johns Hopkins researchers awarded grants for work on potential treatments for diabetes

Three Johns Hopkins University School of Medicine researchers have been awarded two-year grants for their work on potential treatments for diabetes, Novo Nordisk announced this month. Of the 110 initial submissions to the new Novo Nordisk Diabetes and Obesity Biologics Science Forum Program, only four projects were funded, three of which are led by Johns Hopkins researchers. They are Jonathan Powell, M.D., Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, M.D., Ph.D.

19 Apr 2014

Discovery could have far-reaching implications for diagnosis and treatment of diabetic retinopathy

Indiana University researchers have detected new early-warning signs of the potential loss of sight associated with diabetes. This discovery could have far-reaching implications for the diagnosis and treatment of diabetic retinopathy, potentially impacting the care of over 25 million Americans.

17 Apr 2014

SWHR co-sponsors National Institutes of Health Forum on microbiome and autoimmunity

The Society for Women's Health Research (SWHR®), the leading voice on the study of the biological differences between women and men, is co-sponsoring the National Institutes of Health (NIH) Forum on the Microbiome and Autoimmunity on Thursday, April 24, at the NIH in Bethesda, Md.

17 Apr 2014

Study reveals factors that contribute to eye mobility disorder

Imagine you cannot move your eyes up, and you cannot lift your upper eyelid. You walk through life with your head tilted upward so that your eyes look straight when they are rolled down in the eye socket.

17 Apr 2014

Children with Tourette syndrome may unconsciously train brain to effectively control tics

Children with Tourette Syndrome (TS) may unconsciously train their brain to more effectively control their tics.

17 Apr 2014

Iconic Therapeutics completes $20 million Series B-1 equity financing

Iconic Therapeutics, Inc., a biotechnology company focused on developing therapeutics for serious eye disorders, announced today that it has successfully completed a $20 million Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures.

16 Apr 2014

Eye News and Research

Latest Eye News and Research

Free educational event for patients with Graves' disease and thyroid eye disease

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Antimicrobial peptide coated contact lenses may reduce risk of contact lens-related infections

Prestige Brands Holdings signs agreement to acquire Insight Pharmaceuticals for $750 million

NovaBay introduces new eye care product to help patients with eyelids irritation

Kala Pharmaceuticals completes $22.5 million Series B financing

Glaucoma drug may help reverse obesity-related vision loss in women

Sleep disorder is the best current predictor of brain diseases, say U of T researchers

NBTY introduces Nature's Origin, a complete line of nutritional supplements

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Study evaluates stigma and public perceptions related to lung cancer

ResMed launches new nasal and full face masks

Scientists examine Gpr109a receptor to find potential treatment for diabetic retinopathy

U.Va. researchers named recipients of 2013 Hartwell Individual Biomedical Research Awards

Three Johns Hopkins researchers awarded grants for work on potential treatments for diabetes

Discovery could have far-reaching implications for diagnosis and treatment of diabetic retinopathy

SWHR co-sponsors National Institutes of Health Forum on microbiome and autoimmunity

Study reveals factors that contribute to eye mobility disorder

Children with Tourette syndrome may unconsciously train brain to effectively control tics

Iconic Therapeutics completes $20 million Series B-1 equity financing

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Eye News and Research

Latest Eye News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in